Co-Leader, Translational Oncology Program
Omaha, NE
Knight Cancer Institute
Co-Leader, Translational Oncology Program
National Cancer Institute (NCI)
Member, National Cancer Institute, Prevention Steering Committee
Third Coast Therapeutics (3CRx)
Member, Board of Directors; Chief Medical Officer; co-founder; co-owner
National Cancer Institute (NCI)
External Advisory Committee, NCI PREVENT Program
ECOG-ACRIN cancer clinical trials cooperative group
Chair, Prevention Committee
Oregon Health & Science University, Knight Cancer Institute
Associate Director, Knight Cancer Institute, Head, Division of Hematology and Oncology
National Cancer Institute (NCI)
External Advisory Committee, NCI Early Phase Cancer Prevention Program
Northwestern University
Professor of Medicine
National Institutes of Health
investigator
University of Nebraska Medical Center
Deputy Director, Buffett Cancer Center
National Institutes of Health, National Cancer Institute, Bethesda, Maryland
Harvard T.H. Chan School of Public Health
University of Nebraska Medical Center
